Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic

BACKGROUND: To determine how clinicians with a DATA waiver to prescribe buprenorphine for opioid use disorder (OUD) adapted during the COVID-19 pandemic to emergency authorities, including use of telehealth to prescribe buprenorphine, the challenges faced by clinicians, and strategies employed by th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Christopher M., Diallo, Mamadou M., Vythilingam, Meena, Schier, Joshua G., Eisenstat, Matthew, Compton, Wilson M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186054/
https://www.ncbi.nlm.nih.gov/pubmed/34049102
http://dx.doi.org/10.1016/j.drugalcdep.2021.108783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9186054/
https://www.ncbi.nlm.nih.gov/pubmed/34049102
http://dx.doi.org/10.1016/j.drugalcdep.2021.108783

Ejemplares similares